Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters
about
What is the functional role of the thalidomide binding protein cereblon?Glucose deprivation regulates KATP channel trafficking via AMP-activated protein kinase in pancreatic beta-cellsCD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysisMechanistic Pathways of Sex Differences in Cardiovascular Disease.Regulation of ion channels and transporters by AMP-activated kinase (AMPK).Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytesMetabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters.FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.Myocardial macronutrient transporter adaptations in the adult pregestational female intrauterine and postnatal growth-restricted offspring.AMP-activated protein kinase--the fat controller of the energy railroad.Munc18c is not rate-limiting for glucose and long-chain fatty acid uptake in the heartIs membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence.Heart in diabetes: not only a macrovascular disease.Metabolic dysfunction in diabetic cardiomyopathy.Alterations in energy metabolism in cardiomyopathies.Protein-mediated fatty acid uptake: regulation by contraction, AMP-activated protein kinase, and endocrine signals.Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease.Will the original glucose transporter isoform please stand up!Fatty acid metabolism and thyroid hormones.Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy.Metabolic enzymes dysregulation in heart failure: the prospective therapy.Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells).Migration-induced variation of fatty acid transporters and cellular metabolic intensity in passerine birds.Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.Involvement of atypical protein kinase C in the regulation of cardiac glucose and long-chain fatty acid uptake.Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake.Impairment of cardiac insulin signaling in fructose-fed ovariectomized female Wistar rats.5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.Insulin and chromium picolinate induce translocation of CD36 to the plasma membrane through different signaling pathways in 3T3-L1 adipocytes, and with a differential functionality of the CD36.Metoprolol prevents chronic obstructive sleep apnea-induced atrial fibrillation by inhibiting structural, sympathetic nervous and metabolic remodeling of the atria.Effects of AMPK activators on the sub-cellular distribution of fatty acid transporters CD36 and FABPpm.Myocardial Po2 does not limit aerobic metabolism in the postischemic heart.Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria.Ischemia-induced activation of AMPK does not increase glucose uptake in glycogen-replete isolated working rat hearts.Dietary soya protein improves intra-myocardial lipid deposition and altered glucose metabolism in a hypertensive, dyslipidaemic, insulin-resistant rat model.Downregulation of Kv1.5 K channels by the AMP-activated protein kinase.Inhibition of connexin 26 by the AMP-activated protein kinase.Inhibition of the heterotetrameric K+ channel KCNQ1/KCNE1 by the AMP-activated protein kinase.Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.
P2860
Q24635072-3B82C337-9BBA-4647-B494-8CB2C3C890DEQ28566857-A10CEDAD-05D4-4149-ACA3-0388F711CBD5Q28581837-204559DB-BC8E-4F8D-9E4A-8F51FF1C7697Q30241924-80E356D9-4806-42CC-AA87-FC3AD6A9B00CQ30421628-C75A61EE-6F20-45E8-98FE-428E1EBC06B2Q35100504-E4DB7463-3FBA-46D3-8926-83DD971E7105Q35667039-EF8A985A-C048-4230-9FDD-760939579DAAQ35697789-9F4E4128-2EBC-4AAE-BFB1-C00E9EC72AA9Q35879505-5225BCCE-C81D-436C-B7D9-7979E2EA8BD0Q36041879-2F356469-BCB3-49E2-8B36-91ADBA8EC3D6Q36602598-54C7FC62-29E2-4EC9-BC39-6C95E6EBCF70Q36631819-CE8FA8A2-0852-49A2-83E0-866A1173FFC7Q36753522-D5E5DE44-4D41-433C-9998-79A16CCDB1E1Q36783718-7B2F0F03-459D-4D09-BAF3-4AAE7E0D5077Q36930481-8D476BE3-6856-4B01-A4AD-DA60E4F53121Q36970329-0906A349-4E78-4DD4-9950-30580A10F0FCQ37024617-18E3FDCB-2065-465E-BD42-235D558FF004Q37158878-BB68B818-C064-41BE-AC89-90E9A1C66524Q37391748-9F6E5A9D-7A98-4942-8943-FB333C595A9AQ38179362-32C456A0-6727-440E-9FD2-735E1D093CCAQ38861823-B081F3D6-41F6-49F0-92FD-C6ACE2C4FDADQ39011735-BA7A99C2-F4A1-4FA8-80AE-913D5E6762C6Q40056615-45FE4595-7EB3-4416-A39C-BB941A1E5E63Q40715080-2F95FD1B-2B03-4A9F-ACAF-4955B79B1F15Q41104002-2913F9B1-12D0-42B7-8EC2-DB2ED95DF401Q41891892-4185EADA-4777-4DD7-876A-9E14F4CD857AQ42460040-54C5F6E1-83CF-45C7-9B20-AD969692B1A0Q42481952-745FC6F0-9EE2-4F85-B476-5849F986C666Q42497730-BDBB0481-0B86-46A4-9A72-CBA4AF0E3273Q42823436-E7BB792C-777A-4552-A04A-5591635FA338Q43240579-1E12BFE2-62F2-403C-BFD9-4331AF9C41A8Q45990586-1E2696E6-5160-4F46-A634-1E31B03D32E5Q46208090-B744DE4A-8C67-4659-946E-F7BB37298895Q46779978-E075D095-DDAC-4DEE-B0D7-6FC91414A957Q46820269-349BEF47-1ECE-45D6-ADFA-8D0749525FE9Q47263797-F75ED367-2DA9-4F6C-ABBB-002C6376EE16Q48634800-0C505E54-B539-4B23-8394-D0DF718ED826Q48679614-ED6F2F37-3687-469E-B14A-BF7A9E46F77EQ48683488-B034B95D-C6CF-4951-BDAA-FDA6C6044B20Q49247394-957A1AC7-C972-492B-B803-148D05E388E1
P2860
Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Regulation of cardiac long-cha ...... tion of substrate transporters
@ast
Regulation of cardiac long-cha ...... tion of substrate transporters
@en
Regulation of cardiac long-cha ...... tion of substrate transporters
@nl
type
label
Regulation of cardiac long-cha ...... tion of substrate transporters
@ast
Regulation of cardiac long-cha ...... tion of substrate transporters
@en
Regulation of cardiac long-cha ...... tion of substrate transporters
@nl
prefLabel
Regulation of cardiac long-cha ...... tion of substrate transporters
@ast
Regulation of cardiac long-cha ...... tion of substrate transporters
@en
Regulation of cardiac long-cha ...... tion of substrate transporters
@nl
P2093
P921
P1433
P1476
Regulation of cardiac long-cha ...... tion of substrate transporters
@en
P2093
Antonio Zorzano
Arend Bonen
Debby P. Y. Koonen
Dick J. van der Horst
Jan F. C. Glatz
Joost J. F. P. Luiken
P2888
P356
10.1007/S00424-003-1199-4
P50
P577
2004-02-10T00:00:00Z
P5875
P6179
1028574468